Text omitted for confidential treatment. The redacted information has been excluded because it is (i) not material and (ii) the type of information that the registrant customarily and actually treats as private or confidential. SETTLEMENT AGREEMENTSettlement Agreement • August 9th, 2024 • Biote Corp. • Medicinal chemicals & botanical products • Delaware
This Settlement Agreement (“Agreement”) is made by and among biote Corp. (“Biote”), BioTE Medical, LLC (“Medical”), BioTE Holdings, LLC (“Holdings,” and together with Biote and Medical, the “Biote Entities”), Mary Elizabeth Conlon (“Conlon”), Marc D. Beer (“Beer”), Teresa S. Weber (“Weber”), Marci M. Donovitz (“Marci”), the Donovitz Family Irrevocable Trust (“Trust,” and together with Marci, “Donovitz”), Cooley LLP (“Cooley”), Steven J. Heyer, and Haymaker Sponsor III LLC (“Haymaker”) (each a “Party” and together the “Parties”). This Agreement shall become effective as of June 28, 2024 (“Effective Date”).
SECOND AMENDMENT TO CREDIT AGREEMENTCredit Agreement • August 9th, 2024 • Biote Corp. • Medicinal chemicals & botanical products
This SECOND AMENDMENT TO CREDIT AGREEMENT (this “Agreement”), dated as of June 26, 2024 (the “Second Amendment Effective Date”), is entered into by and among BIOTE MEDICAL, LLC, a Texas limited liability company (the “Borrower”), BIOTE HOLDINGS, LLC, a Delaware limited liability company (“Holdings”), the other Guarantors party hereto, the Lenders party hereto, and Truist Bank, as the Administrative Agent (the “Administrative Agent”).
CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMSSeparation Agreement • August 9th, 2024 • Biote Corp. • Medicinal chemicals & botanical products • Texas
This is a Confidential Separation Agreement and General Release of Claims (“Agreement”) by and between Mary Puncochar (“Employee”) and BioTE Medical, LLC, a Texas limited liability company (together with its affiliates, parents, and subsidiaries the “Company”). Employee and Company collectively are referred to herein as the “Parties” or singularly as a “Party.”
FIRST AMENDMENT TO CREDIT AGREEMENT AND WAIVERCredit Agreement • August 9th, 2024 • Biote Corp. • Medicinal chemicals & botanical products
This FIRST AMENDMENT TO CREDIT AGREEMENT AND WAIVER (this “Agreement”), dated as of April 26, 2024 (the “First Amendment Effective Date”), is entered into by and among BIOTE MEDICAL, LLC, a Texas limited liability company (the “Borrower”), BIOTE HOLDINGS, LLC, a Delaware limited liability company (“Holdings”), the other Guarantors party hereto, the Lenders party hereto, and Truist Bank, as the Administrative Agent (the “Administrative Agent”).
